Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
Chinese Patent Office
Medtronic
Fuji
Fish and Richardson
Boehringer Ingelheim
Covington
Baxter

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065079

« Back to Dashboard

NDA 065079 describes PENICILLIN G POTASSIUM, which is a drug marketed by Mylan, Purepac Pharm, Apothecon, Consolidated Pharm, Hanford Gc, Istituto Bio Ita Spa, Lilly, Parke Davis, Pfizer, Sandoz, Watson Labs Inc, Ivax Sub Teva Pharms, Teva, Wyeth Ayerst, and Baxter Hlthcare, and is included in twenty NDAs. It is available from three suppliers. Additional details are available on the PENICILLIN G POTASSIUM profile page.

The generic ingredient in PENICILLIN G POTASSIUM is penicillin g potassium. There are ninety drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the penicillin g potassium profile page.
Summary for 065079
Tradename:PENICILLIN G POTASSIUM
Applicant:Sandoz
Ingredient:penicillin g potassium
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 065079
Ingredient-typePenicillins
Suppliers and Packaging for NDA: 065079
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PENICILLIN G POTASSIUM penicillin g potassium INJECTABLE;INJECTION 065079 ANDA Sandoz Inc 0781-6135 N 0781-6135-95
PENICILLIN G POTASSIUM penicillin g potassium INJECTABLE;INJECTION 065079 ANDA Sandoz Inc 0781-6136 N 0781-6136-94

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength1,000,000 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Aug 30, 2002TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5,000,000 UNITS/VIAL
Approval Date:Aug 30, 2002TE:APRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20,000,000 UNITS/VIAL
Approval Date:Aug 30, 2002TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
UBS
Chinese Patent Office
Healthtrust
Cerilliant
Colorcon
Dow
Accenture
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.